XtalPi: China has clear advantages in developing AI-driven drugs

English Español Français العربية Русский

RSS Newsletters

Radio TV

Newsletters
RSS

LANGUAGE
English Español Français العربية Русский Documentary CCTV+

Radio TV

Download

01:49

Chinese companies have an edge in developing drugs with the help of AI, thanks to the country's advanced hardware, talent pool, and robust supply chain, according to Wen Shuhao, co-founder and chairman of XtalPi. He noted that this made China a favorable option for international businesses expanding in this field.